The Spanish version of the Warwick-Edinburgh mental well-being scale (WEMWBS) is valid for use in the general population.
Pere Castellví, Carlos G Forero, Miquel Codony...
https://pubmed.ncbi.nlm.nih.gov/24005886/Actively Recruiting
Led by Corporació de Salut del Maresme i la Selva · Updated on 2025-05-30
200
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating an interdisciplinary, community-based program called Reforat designed to reduce 30-day hospital readmissions and improve functional outcomes in patients aged 65 or older with chronic heart, lung, or mixed conditions after hospital discharge. The study aims to see if Reforat can lower readmission rates to 25% compared to standard care and improve medication adherence, quality of life, and survival. Patients will be compared between those receiving Reforat and those under usual care to assess health outcomes and cost-effectiveness. The intervention includes a full-scale program with interdisciplinary care, home follow-ups, therapeutic optimization, functional rehabilitation, health education, and psychosocial support. The trial also includes a feasibility phase and long-term follow-up. The intervention group receives presential follow-up by a multidisciplinary team, while the control group receives standard hospital-at-home care. Follow-up assessments occur at 3, 6, 9, and 12 months after discharge to monitor hospital readmissions, survival, nursing home admissions, and overall well-being. Participants will undergo assessments before and after the intervention, with a post-discharge evaluation at 30 days and continued monitoring up to 12 months. Researchers will collect data on readmissions, mortality, functional decline, medication adherence, risk of falls, social isolation, emotional well-being, and caregiver burden. Patient satisfaction and smoking cessation rates are also measured. This comprehensive evaluation aims to determine the programs impact on health outcomes and quality of life in older adults with chronic cardiorespiratory conditions.
CONDITIONS
Reforça't: A Community, Social, and Healthcare Program for Patients With Cardiorespiratory Conditions Upon Hospital Discharge
G
Griselda Manzano Monfort
N
Noelia Quirant Arellano
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Corporació de Salut del Maresme i la Selva
Lead Sponsor
Consorci Sanitari de Terrassa
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person)
Duration - Approximately 5.5 months
Participants receive interdisciplinary care including home follow-ups, therapeutic optimization, functional rehabilitation, health education, and psychosocial support after hospital discharge.
Presential follow-up visits by a multidisciplinary team during the intervention period
Duration - Up to 1 year after intervention ends
Participants are followed up at 3, 6, 9, and 12 months post-intervention to evaluate hospital readmissions, mortality, and other health outcomes.
Follow-up assessments at 3, 6, 9, and 12 months post-intervention
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Pere Castellví, Carlos G Forero, Miquel Codony...
https://pubmed.ncbi.nlm.nih.gov/24005886/Rüya-Daniela Kocalevent, Lorenz Berg, Manfred E Beutel...
https://pubmed.ncbi.nlm.nih.gov/30016997/Claudia Di Chiara, Giulia Sartori, Alberto Fantin...
https://pubmed.ncbi.nlm.nih.gov/39859079/Jonathan Miranda, Danielle Underwood, Miranda Kuepfer-Thomas...
https://pubmed.ncbi.nlm.nih.gov/31893574/David O Arnar, Saemundur J Oddsson, Thrudur Gunnarsdottir...
https://pubmed.ncbi.nlm.nih.gov/36451212/Eric A Coleman, Jodi D Smith, Janet C Frank...
https://pubmed.ncbi.nlm.nih.gov/15507057/Mauro Laudicella, Paolo Li Donni, Peter C Smith
https://pubmed.ncbi.nlm.nih.gov/23938273/Lucy Doos, Eleanor Bradley, Claire A Rushton...
https://pubmed.ncbi.nlm.nih.gov/24831061/Rachael C Walker, Allison Tong, Kirsten Howard...
https://pubmed.ncbi.nlm.nih.gov/30784430/Juan José Zamora-Sánchez, Edurne Zabaleta-Del-Olmo, Vicente Gea-Caballero...
https://pubmed.ncbi.nlm.nih.gov/35307198/Corporació de Salut del Maresme i la Selva
Lead Sponsor
Consorci Sanitari de Terrassa
Collaborating Sponsor